Last reviewed: June 26, 2026
Last updated: June 26, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
The 1.7 milligram dose of semaglutide sits in the middle maintenance range of GLP-1 therapy, producing an average weight loss of 8–12% of body weight in clinical settings. However, whether this dose is strong enough for your specific weight loss goals depends on your unique physiology, genetic makeup, and how your body's peptide pathways respond to the medication.
How Much Weight Loss Does 1.7mg Semaglutide Produce?
Clinical data shows that patients taking 1.7 milligrams of semaglutide typically lose between 8 and 12 percent of their starting body weight over 16 weeks of consistent treatment. For a person weighing 250 pounds, this translates to approximately 20–30 pounds of fat loss while maintaining muscle mass. This level of weight reduction significantly reduces the risk of type 2 diabetes, lowers blood pressure, and improves cardiovascular markers in most patients.
The 1.7 dose is designed to balance efficacy with tolerability—it's high enough to activate GLP-1 receptors throughout the brain and gut, yet low enough to minimize nausea and gastrointestinal side effects that sometimes occur at higher concentrations. Response varies: some individuals see steady progress at this dose, while others plateau and may benefit from dose escalation to 2.4 milligrams or combination therapy with tirzepatide.
Factors That Determine if 1.7mg Is Strong Enough
Your genetic structure plays a crucial role in how well semaglutide works at any given dose. The GLP1R rs6923761 variant and the FTO rs9939609 genetic marker influence how efficiently your body's GLP-1 receptors bind to the medication and regulate appetite signaling. Individuals with certain genetic profiles may need higher doses to achieve the same weight loss as others at 1.7 milligrams, while those with favorable genetic predispositions may experience excellent results at this maintenance level.
Additional factors include your metabolic baseline (resting metabolic rate), starting body weight, adherence to dietary guidelines, exercise frequency, sleep quality, and stress hormone levels. A person with a high baseline metabolism may require dose escalation sooner, whereas someone with significant insulin resistance may benefit from adding tirzepatide—which targets an additional peptide pathway—rather than increasing semaglutide alone.
When to Stay at 1.7mg Versus Increasing Your Dose
Staying at 1.7 milligrams is appropriate if you're experiencing consistent, steady weight loss each month without significant weight-loss plateaus, tolerating the dose well with minimal side effects, meeting your personal weight loss timeline, and improving metabolic markers like fasting glucose and cholesterol levels. Many people see sustained results for 4–6 months at this dose before any plateau occurs.
You may consider dose escalation if you've been on 1.7 milligrams for 8+ weeks with no weight loss, have reached a plateau lasting 3+ weeks despite diet and exercise compliance, or are not progressing toward your physician-recommended weight loss target. Some patients benefit from switching to a dual-compound approach—like GLP-Squared Injection, which combines semaglutide and tirzepatide—rather than further increasing a single agent. PlexusDx clinicians evaluate your response data and genetics to recommend the most effective next step.
Genetic Testing and Personalized Dose Optimization
PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptide variants to reveal how your body responds to GLP-1 therapy at a molecular level. The test examines key genetic markers including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—variants that directly predict your semaglutide efficacy and optimal dose range. This insight eliminates guesswork and helps patients and clinicians decide faster whether 1.7 milligrams is sufficient or if a different compound or dose strategy will produce better outcomes.
Adding the Precision Peptide Genetic Test after your first month of semaglutide treatment costs $99 and provides over 150 clinical insights about your peptide metabolism. Patients who know their genetic profile often reach their weight loss goals 4–8 weeks faster than those relying on trial-and-error dosing, because the test reveals whether your body would respond better to tirzepatide, a dual-compound protocol, or oral versus injection formulations.
PlexusDx Semaglutide Options and Pricing
PlexusDx offers compounded semaglutide injections from licensed 503A compounding pharmacies starting at $149 per month, with no insurance required and HSA/FSA eligibility. Your dose may need to go up—our pricing doesn't: the flat monthly rate covers all dose adjustments needed to reach your weight loss target, removing financial barriers to optimal therapy. Oral semaglutide is also available starting at $249 per month for patients preferring tablet-based treatment.
PlexusDx serves all 50 states and works with you to find the right starting dose and titration schedule based on your medical history and body composition. If 1.7 milligrams isn't producing the results you need, switching to tirzepatide ($249/mo injection) or the GLP-Squared combination ($249/mo injection) can be done immediately without changing your monthly investment, letting you find the most effective therapy for your unique genetics and metabolism.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Will 1.7mg semaglutide work if I'm very overweight or have severe obesity?
The 1.7 milligram dose can produce meaningful weight loss across all weight categories, though people with higher baseline body weight sometimes benefit from faster dose escalation or dual-compound therapy. PlexusDx clinicians review your starting weight and weight loss velocity at week 4–6 to determine if 1.7mg is optimal or if advancing to tirzepatide or GLP-Squared will accelerate your results within your timeline.
How long does it take to see weight loss at the 1.7mg dose?
Most patients notice appetite reduction within 3–7 days and measurable weight loss (2–4 pounds) within the first 2–3 weeks of consistent 1.7mg dosing. Continued linear weight loss typically occurs for 12–24 weeks before any plateau; the timeline varies based on diet consistency, activity level, and individual metabolism.
Can I start at 1.7mg or do I have to begin at a lower dose?
Standard GLP-1 protocols begin with lower doses (0.25–0.5mg) and titrate upward weekly to minimize side effects and allow your body to adapt. However, some patients and clinicians may choose faster titration schedules; PlexusDx works with you to determine the safest, most effective initiation plan for your medical history.
What happens if 1.7mg stops working after a few months?
Weight loss plateaus are common after 8–12 weeks at any dose and don't mean the medication is failing. PlexusDx typically recommends either increasing to the next dose tier, switching to tirzepatide, or combining both compounds via GLP-Squared Injection to re-engage additional peptide pathways and overcome the plateau.
Will genetic testing tell me if I need more than 1.7mg semaglutide?
Yes. The PlexusDx Precision Peptide Genetic Test analyzes GLP1R and FTO variants that predict your semaglutide response curve, revealing whether you're a rapid responder (may plateau sooner), standard responder, or slow responder who may benefit from higher doses or tirzepatide from the start. This test ($99 add-on after month one) helps you reach your goals faster.
Is compounded semaglutide as effective as brand-name Wegovy at 1.7mg?
Compounded semaglutide from licensed 503A pharmacies contains the identical active pharmaceutical ingredient as Wegovy and delivers the same clinical efficacy when dosed at 1.7 milligrams. PlexusDx compounds are produced under strict pharmaceutical standards and cost significantly less—starting at $149/month—making consistent, long-term therapy more affordable.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
When Do You Notice Ozempic Working? Navigating Your Personalized Weight Loss Journey
Optimizing Your Zepbound Experience: Should You Take It in the Morning or at Night?